Supernus Pharmaceuticals
SUPN
#4047
Rank
A$4.21 B
Marketcap
A$73.25
Share price
-1.87%
Change (1 day)
33.97%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of December 2025 : A$2.10 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are A$2.10 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2025-12-31A$2.16 B-1.4%
2024-12-31A$2.19 B17.28%
2023-12-31A$1.87 B-25.04%
2022-12-31A$2.50 B7.38%
2021-12-31A$2.32 B19.11%
2020-12-31A$1.95 B18.04%
2019-12-31A$1.65 B19.4%
2018-12-31A$1.38 B155.29%
2017-12-31A$0.54 B26.6%
2016-12-31A$0.42 B65.86%
2015-12-31A$0.25 B54.92%
2014-12-31A$0.16 B34.31%
2013-12-31A$0.12 B37.58%
2012-12-31A$90.44 M72.6%
2011-12-31A$52.4 M13.23%
2010-12-31A$46.27 M-47.97%
2009-12-31A$88.94 M-18.65%
2008-12-31A$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$289.07 B 13,613.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$125.83 B 5,869.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$163.21 B 7,642.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$130.65 B 6,098.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$11.43 B 442.46%๐Ÿ‡บ๐Ÿ‡ธ USA